ANGLE plc (LON:AGL – Get Free Report) passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 11.26 ($0.14) and traded as low as GBX 10.50 ($0.13). ANGLE shares last traded at GBX 11.22 ($0.14), with a volume of 865,932 shares changing hands.
Analyst Upgrades and Downgrades
Separately, Berenberg Bank restated a “buy” rating and issued a GBX 70 ($0.85) price target on shares of ANGLE in a research report on Thursday, September 26th.
View Our Latest Report on ANGLE
ANGLE Stock Performance
About ANGLE
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD.
Recommended Stories
- Five stocks we like better than ANGLE
- Trading Stocks: RSI and Why it’s Useful
- AI Demand Sparks Opportunities for These 3 Nuclear Energy Leaders
- Investing in Commodities: What Are They? How to Invest in Them
- TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
- What is a SEC Filing?
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside
Receive News & Ratings for ANGLE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE and related companies with MarketBeat.com's FREE daily email newsletter.